Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study

Open access
Young, Ken H., Leroy, Karen, Møller, Michael B., Colleoni, Gisele W. B., Sánchez-Beato, Margarita, Kerbauy, Fábio R., Haioun, Corinne, Eickhoff, Jens C., Young, Allen H., Gaulard, Philippe, Piris, Miguel A., Oberley, Terry D., Rehrauer, William M., Kahl, Brad S., Malter, James S., Campo, Elias, Delabie, Jan, Gascoyne, Randy D., Rosenwald, Andreas, Rimsza, Lisa, Huang, James, Braziel, Rita M., Jaffe, Elaine S., Wilson, Wyndham H., Staudt, Louis M., Vose, Julie M., Chan, Wing C., Weisenburger, Dennis D., Greiner, Timothy C. · 2008 · Blood

Abstract

The purpose of this study is to correlate the presence of TP53 gene mutations with the clinical outcome of a cohort of patients with diffuse large B-cell lymphoma (DLBCL) assembled from 12 medical centers. TP53 mutations were identified in 102 of 477 patients, and the overall survival (OS) of patients with TP53 mutations was significantly worse than those with wild-type TP53 (P < .001). However, subsets of TP53 mutations were found to have different effects on OS. Mutations in the TP53 DNA-binding domains were the strongest predictors of poor OS (P < .001). Mutations in the Loop-Sheet-Helix and Loop-L3 were associated with significantly decreased OS (P = .002), but OS was not significantly affected by mutations in Loop-L2. A subset of missense mutations (His158, His175, Ser245, Gln248, His273, Arg280, and Arg282) in the DNA-binding domains had the worst prognosis. Multivariate analysis confirmed that the International Prognostic Index and mutations in the DNA-binding domains were independent predictors of OS. TP53 mutations also stratified patients with germinal center B cell–like DLBCL, but not nongerminal center B cell–like DLBCL, into molecularly distinct subsets with different survivals. This study shows the prognostic importance of mutations in the TP53 DNA-binding domains in patients with DLBCL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2008-01-129783

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 191

Metadata

Authors
Young, K. H., Leroy, K., Møller, M. B., Colleoni, G. W. B., Sánchez-Beato, M., Kerbauy, F. R., Haioun, C., Eickhoff, J. C., Young, A. H., Gaulard, P., Piris, M. A., Oberley, T. D., Rehrauer, W. M., Kahl, B. S., Malter, J. S., Campo, E., Delabie, J., Gascoyne, R. D., Rosenwald, A., Rimsza, L., Huang, J., Braziel, R. M., Jaffe, E. S., Wilson, W. H., Staudt, L. M., Vose, J. M., Chan, W. C., Weisenburger, D. D., & Greiner, T. C.
Venue
Blood
Published
2008-10-15
Volume
112
Issue
8
Pages
3088-3098
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2022013393
Cited by
191
References
4
FWCI
8.64
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. https://app.cochat.ai/papers/10.1182/blood-2008-01-129783
The paper
Young, K. H., Leroy, K., Møller, M. B., Colleoni, G. W. B., Sánchez-Beato, M., Kerbauy, F. R., Haioun, C., Eickhoff, J. C., Young, A. H., Gaulard, P., Piris, M. A., Oberley, T. D., Rehrauer, W. M., Kahl, B. S., Malter, J. S., Campo, E., Delabie, J., Gascoyne, R. D., Rosenwald, A., . . . Greiner, T. C. (2008). Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood. https://doi.org/10.1182/blood-2008-01-129783

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.